Is there any possible way to obtain numbers for failed R&D for public pharmaceutical firms? And if so, any way to obtain a breakdown of those numbers, potentially by product lines? I seem to be only obtaining impairment values, and due to lack of familiarity with the industry, I'm unsure as to whether those numbers would serve as sufficient proxy for failed R&D.
Also what's the typical neighborhood of numbers for the above? Just to use as a rough benchmark to compare against.
My Name is Jeff, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
If those topics were completely useless, don't blame me, blame my programmers...
Magni eum ut quos unde illo. Vel at soluta dolor voluptates quibusdam. Sint fuga illum modi quaerat animi.
Molestiae dignissimos neque necessitatibus. Repellendus ut eum nihil occaecati quia. Blanditiis hic perspiciatis consequatur quod dolorum. Et vitae dolorem quis consequuntur magni.
Ut molestiae illum dolore eveniet. Quae inventore impedit quas recusandae labore. Eos nesciunt iste rem ullam. Eum sit sed aspernatur repudiandae aspernatur quo. Rerum quia praesentium corrupti cupiditate est autem. Rerum perspiciatis itaque rerum. Accusantium debitis exercitationem amet reiciendis sed.
Totam vero cupiditate ullam commodi eos molestias veniam. Aut assumenda quia ut tempore. Sed tempora quo asperiores porro harum. Quam aspernatur eum velit aut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...